These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7846286)

  • 1. Benzodiazepines and anxiety sensitivity in panic disorder.
    Fava GA; Grandi S; Belluardo P; Savron G; Raffi AR; Conti S; Saviotti FM
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Nov; 18(7):1163-8. PubMed ID: 7846286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine treatment of panic and agoraphobic symptoms: use, dependence, toxicity, abuse.
    Salzman C
    J Psychiatr Res; 1993; 27 Suppl 1():97-110. PubMed ID: 7908335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of gradual discontinuation of selective serotonin reuptake inhibitors in panic disorder with agoraphobia.
    Fava GA; Bernardi M; Tomba E; Rafanelli C
    Int J Neuropsychopharmacol; 2007 Dec; 10(6):835-8. PubMed ID: 17224089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term drug treatment of panic disorder.
    Burrows GD; Judd FK; Norman TR
    J Psychiatr Res; 1993; 27 Suppl 1():111-25. PubMed ID: 7908330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder.
    Moylan S; Staples J; Ward SA; Rogerson J; Stein DJ; Berk M
    J Clin Psychopharmacol; 2011 Oct; 31(5):647-52. PubMed ID: 21869686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical picture and treatment of agoraphobia with panic disorder].
    Litvintsev SV; Reznik AM; Kvashnina NV; Arbuzov AL; Krylov KE
    Voen Med Zh; 2003 Jun; 324(6):53-9. PubMed ID: 12916423
    [No Abstract]   [Full Text] [Related]  

  • 7. Alpidem in the treatment of panic disorder.
    Schneier FR; Carrasco JL; Hollander E; Campeas R; Fallon B; Saoud JB; Feerick J; Liebowitz MR
    J Clin Psychopharmacol; 1993 Apr; 13(2):150-3. PubMed ID: 8096527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional classification of anxiety-panic.
    Liebowitz MR
    Int Clin Psychopharmacol; 1993 Sep; 8 Suppl 1():47-52. PubMed ID: 7902853
    [No Abstract]   [Full Text] [Related]  

  • 9. [Panic disorder and agoraphobia: what is effective?].
    Bandelow B; Sievert K; Röthemeyer M; Hajak G; Broocks A; Rüther E
    Fortschr Neurol Psychiatr; 1995 Nov; 63(11):451-64. PubMed ID: 8575719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personality dimensions in panic disorder before and after effective treatment.
    Starcevic V; Uhlenhuth EH
    Anxiety; 1996; 2(2):95-8. PubMed ID: 9160608
    [No Abstract]   [Full Text] [Related]  

  • 11. Adinazolam-SR in panic disorder with agoraphobia: relationship of daily dose to efficacy.
    Carter CS; Fawcett J; Hertzman M; Papp LA; Jones W; Patterson WM; Swinson RP; Weise CC; Maddock RJ; Denahan AQ
    J Clin Psychiatry; 1995 May; 56(5):202-10. PubMed ID: 7737960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepines for panic disorder. Are they safe?
    Garvey M
    Postgrad Med; 1991 Oct; 90(5):245-6, 249-52. PubMed ID: 1681526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 15-year follow-up study of patients with panic disorder.
    Andersch S; Hetta J
    Eur Psychiatry; 2003 Dec; 18(8):401-8. PubMed ID: 14680716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased probability of remaining in remission from panic disorder with agoraphobia after drug treatment in patients who received concurrent cognitive-behavioural therapy: a follow-up study.
    Biondi M; Picardi A
    Psychother Psychosom; 2003; 72(1):34-42. PubMed ID: 12466636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panic disorder: guidelines to safe use of benzodiazepines.
    Garvey MJ
    Geriatrics; 1993 Jul; 48(7):49-53, 56-8. PubMed ID: 8100794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive treatment of benzodiazepine discontinuation syndromes: a review.
    Roy-Byrne PP; Sullivan MD; Cowley DS; Ries RK
    J Psychiatr Res; 1993; 27 Suppl 1():143-53. PubMed ID: 7908331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crossover trial of pagoclone and placebo in patients with DSM-IV panic disorder.
    Sandford JJ; Forshall S; Bell C; Argyropoulos S; Rich A; D'Orlando KJ; Gammans RE; Nutt DJ
    J Psychopharmacol; 2001 Sep; 15(3):205-8. PubMed ID: 11565630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alprazolam in panic disorder: a retrospective analysis.
    Shelton RC; Harvey DS; Stewart PM; Loosen PT
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 May; 17(3):423-34. PubMed ID: 8475324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuation reactions to alprazolam in panic disorder.
    Pecknold JC
    J Psychiatr Res; 1993; 27 Suppl 1():155-70. PubMed ID: 8145176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.
    Pols H; Verburg K; Hauzer R; Meijer J; Griez E
    Biol Psychiatry; 1996 Nov; 40(9):913-7. PubMed ID: 8896779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.